Targeted treatment with pegcetacoplan for adolescents with C3G or primary (idiopathic) IC-MPGN in the VALIANT phase 3 trial

Overview of attention for article published in Immunobiology, July 2025

Altmetric Badge

Mentioned by

twitter: 1 X user

bluesky: 1 Bluesky user

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 2,305 followers.

Targeted treatment with pegcetacoplan for adolescents with C3G or primary (idiopathic) IC-MPGN in the VALIANT phase 3 trial https://t.co/4z1bvahkHo #ScientiaVH

Targeted treatment with pegcetacoplan for adolescents with C3G or primary (idiopathic) IC-MPGN in the VALIANT phase 3 trial https://t.co/yLjiJhfx0p #hvhebron #nefroped [Text complet]

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.